Biotech | July 24, 2023
This product will be launched through Granules Consumer Health (GCH) division
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore
Marksans' OTC Famotidine Tablets USP are acid reducers
Natco launched pomalidomide under their brand NAT-POMALIDOMIDE in strengths of 1 mg, 2 mg, 3 mg and 4 mg capsules
Subscribe To Our Newsletter & Stay Updated
